Viewing Study NCT03930732


Ignite Creation Date: 2025-12-24 @ 9:45 PM
Ignite Modification Date: 2025-12-29 @ 1:45 AM
Study NCT ID: NCT03930732
Status: COMPLETED
Last Update Posted: 2024-02-28
First Post: 2019-04-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation
Sponsor: Sanofi
Organization: